Sotera Health Company (NASDAQ:SHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Sotera Health Company (NASDAQ:SHC) have earned an average rating of “Moderate Buy” from the ten brokerages that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $20.00.

A number of research firms have weighed in on SHC. Barclays boosted their target price on shares of Sotera Health from $19.00 to $20.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. William Blair initiated coverage on Sotera Health in a research report on Thursday, December 18th. They set an “outperform” rating for the company. Zacks Research upgraded Sotera Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 1st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 29th. Finally, Wells Fargo & Company downgraded shares of Sotera Health to an “overweight” rating in a research report on Thursday, January 8th.

Insider Transactions at Sotera Health

In related news, CEO Michael B. Jr. Petras sold 434,104 shares of the company’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $16.45, for a total transaction of $7,141,010.80. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Gtcr Investment Xi Llc sold 12,000,000 shares of the stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $15.65, for a total value of $187,800,000.00. Following the transaction, the director owned 29,215,301 shares in the company, valued at $457,219,460.65. The trade was a 29.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 29,384,104 shares of company stock valued at $471,824,511. Corporate insiders own 47.55% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

Large investors have recently modified their holdings of the company. Empowered Funds LLC increased its stake in Sotera Health by 11.1% during the 1st quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after purchasing an additional 2,845 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Sotera Health by 14.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock valued at $3,999,000 after acquiring an additional 43,471 shares in the last quarter. Acadian Asset Management LLC boosted its stake in Sotera Health by 125.5% during the 1st quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after purchasing an additional 14,018 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of Sotera Health by 124.0% in the second quarter. Parallel Advisors LLC now owns 3,340 shares of the company’s stock worth $37,000 after purchasing an additional 1,849 shares during the last quarter. Finally, UMB Bank n.a. lifted its holdings in shares of Sotera Health by 112.8% in the second quarter. UMB Bank n.a. now owns 2,635 shares of the company’s stock valued at $29,000 after purchasing an additional 1,397 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Trading Down 0.9%

NASDAQ SHC opened at $19.18 on Friday. Sotera Health has a twelve month low of $9.53 and a twelve month high of $19.85. The business’s fifty day moving average is $17.27 and its 200 day moving average is $15.62. The company has a quick ratio of 2.18, a current ratio of 2.38 and a debt-to-equity ratio of 4.04. The company has a market cap of $5.45 billion, a price-to-earnings ratio of 100.95 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, November 4th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.22 by $0.04. The firm had revenue of $311.31 million during the quarter, compared to the consensus estimate of $303.63 million. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. As a group, sell-side analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.